[en] A solid-phase ELISA was set up to measure the direct binding capacity (BC) of different, commercially available, purified human IgA preparations to plates coated with human fibronectin (FN). It was found that secretory, polymeric, and, to a much lesser extent, monomeric IgA exhibited elevated FN-BC as compared to their BC to plates coated with bovine serum albumin. This binding was specific since not observed with human IgG or IgM antibodies. In addition, we noted that this interaction was dose dependent, Ca2+ dependent, saturable, and not covalent, was inhibited by soluble FN, but not by a prior incubation of FN-coated plates with anti-human fibronectin antibodies, and appeared to involve on the dimeric FN other structures than its heparin-binding, collagen-binding, or C1q-binding domains. Similar experiments conducted with normal plasma indicated that plasma IgA, but not plasma IgG or IgM, was also capable of significant binding to FN-coated plates. In contrast, serum IgA did not significantly bind to those plates under otherwise identical experimental conditions. Thus, the coagulation process induces a strong decrease in the FN-BC of circulating IgA, which implies the necessity of using plasma rather than serum to study such interactions. The apparent molecular weight of plasma IgA interacting with FN-coated plates ranged between 450 and 900 kd, and its major binding characteristics were quite similar to those observed with purified polymeric IgA. The FN-BC of plasma IgA was then measured by the same ELISA in 30 patients with primary IgA nephropathy (IgAN) and in 23 healthy controls. The mean FN-BC of plasma IgA was significantly higher in patients than in normal controls. This enhancement was due mainly to the augmentation in the concentration of circulating "macromolecular" IgA and was significantly correlated with the plasma levels of IgA-FN complexes. However, the pathogenetic role of these findings was probably not determinant since similar observations were made in alcoholic liver cirrhosis without urinary abnormalities and since the FN-BC of plasma IgA or the plasma levels of IgA-FN complexes were not correlated with the various biological parameters of evolutivity of primary IgAN. In conclusion, these studies suggest that the ability of polymeric IgA to directly bind to FN is involved in the formation of circulating IgA-FN complexes and that this normal binding process, although enhanced in IgAN, is probably not responsible for kidney injury, at least in the patients studied.
Woodroffe A.J. (1987) Summary of the pathogenesis of IgA nephropathy. IgA Nephropathy , A.R., Clarkson, Martinus Nijhoff, Boston, Dordrecht, Lancaster; 204-213.
Monteiro R.C., Halbwachs-Mecarelli L., Roque-Barreira M.C., Oel L.H., Berger J., Lesavre T.H. (1985) Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671.
Davin J.C., Dechenne C., Lombet J., Rentier B., Foidart J.B., Mahieu P.R. (1989) Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes. Virchows Arch A Pathol Anat 415:7-20.
Cosio F.G., Bakaletz A.P. (1987) Role of fibronectin on the clearance and tissue uptake of antigen and immune complexes in rats. J Clin Invest 80:1270-1279.
Cederholm B., Wieslander J., Bygren N.P., Heinegard D. (1988) Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 88:4865-4868.
McDonagh J. Plasma Fibronectin, Structure and Function , J., McDonagh, Marcel Dekker, New York, Basel; 1985, 1-5.
Egido J. (1987) The role of polymeric IgA in the pathogenesis of IgA nephropathy. IgA Nephropathy , A.R., Clarkson, Martinus Nijhoff, Boston, Dordrecht, Lancaster; 157-175.
Delacroix D.L., Elkon K.B., Geubel A.P., Hodgson H.F., Dive C., Vaerman J.P. (1982) Changes in size, subclass and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71:358-367.
Damas P., Adam A., Closset J., Calay G., Foidart J.M., Lamy M., Foidart J., Mahieu P.R. (1986) An enzyme-linked immunoassay for direct measurement of the gelatin-binding capacity of human plasma fibronectin. J Immunol Meth 91:205-211.
Scheidegger J.J. (1955) Une microméthode de l'immunoélectrophrèse. Int Arch Allergy Appl Immunol 7:103-110.
Mancini G., Carbonara A.D., Heremans J-F (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235-254.
Jones C., Mermelstein N., Kincaid-Smith P., Powell H., Roberton D. (1988) Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay. Clin Exp Immunol 72:344-349.
Underdown B.J., De Rose J., Koczehan K., Socken D., Weiker J. (1977) Isolation of human secretory component by affinity chromatography on IgM-Sepharose. Immunochemistry 14:111-117.
Davin J.C., Foidart J.B., Mahieu P.R. (1987) Relation between biological IgA abnormalities and mesangial IgA deposits in isolated hematuria in childhood. Clin Nephrol 28:73-80.
Snedecor G.W. (1952) Queries. Biometrics 8:85-88.
Kauffman R.H., Van Es L.A., Daha (1981) The specific detection of IgA in immune complexes. Journal of Immunological Methods 40:117-129.
Cederholm B., Wieslander J., Bygren P., Heinegard D. (1986) Patients with antibodies reacting with structures common to collagen I, II and IV. Proc Natl Acad Sci USA 83:6151-6155.
Davin J.C., Malaise M., Foidart J., Mahieu P.R. (1987) Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura or IgA nephropathy. Kidney Int 31:1132-1139.
McDonagh J., Hada M., Kaminski M. (1985) Plasma fibronectin and fibrin formation. Plasma Fibronectin Structure and Function , J., McDonagh, Marcel Dekker, New York, Basel; 121-148.
Mestecky J., Tomana M., Czerkinsky C., Tarkowski A., Matsuda S., Waldo F.B., Moldoveanu Z., Julian B.A., Galla J.H., Russell M.W., Jackson S. (1987) IgA-associated renal diseases: Immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions. Semin Nephrol 7:332-335.
Wright S.D., Christoph Meyer B. (1986) Fibronectin receptor of human macrophages recognizes the sequence: Arg-Gly-Asp-Ser. J Exp Med 162:762-767.
Lagrue G., Hribec G., Fournel M., Intrator L. (1973) Glomerulonéphrite mésangiale à dépôts d'IgA: Études des immunoglobulines sériques. J Urol Nephrol 80:385-386.
Mosher D.F. (1984) Physiology of fibronectin. Ann Rev Med 35:561.
Gonzalez-Calvin J., Scully M.F., Sanger Y. (1982) Fibronectin in fulminant hepatic failure. Br Med J 285:1231.
Ng W.L., Chan K.W., Yeung C.K., Kwan S. (1984) Peripheral glomerular capillary wall lesions in IgA nephropathy and their implications. Pathology 16:324-330.
Turi S., Nagy J., Haszon I., Havass Z., Nemeth M., Bereczki C. (1989) Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura. Pediatric Nephrology 3:61-67.
Malaise M.G., Franchimoni P., Gomez F., Bouillenne C., Mahieu P.R. (1987) The spontaneous ability of human IgG to inhibit the FC receptors of normal human monocytes is related to their binding capacity to lectins. Clin Immunol Immunopathol 45:1-7.